DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,565 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $65,935,000 | +7.8% | 296,814 | +4.5% | 4.38% | -5.3% |
| Q3 2020 | $61,187,000 | +14.0% | 284,153 | -6.4% | 4.62% | +1.1% |
| Q2 2020 | $53,660,000 | +35.0% | 303,460 | +5.7% | 4.57% | -2.1% |
| Q1 2020 | $39,751,000 | -16.3% | 287,195 | -7.2% | 4.67% | -0.9% |
| Q4 2019 | $47,492,000 | +16.3% | 309,437 | +9.5% | 4.71% | +1.7% |
| Q3 2019 | $40,819,000 | +4.6% | 282,618 | +3.5% | 4.63% | -0.2% |
| Q2 2019 | $39,028,000 | +9.0% | 273,092 | +0.7% | 4.64% | +1.9% |
| Q1 2019 | $35,795,000 | +15.3% | 271,131 | -9.9% | 4.55% | -2.2% |
| Q4 2018 | $31,039,000 | -9.9% | 301,001 | -5.1% | 4.66% | +1.6% |
| Q3 2018 | $34,467,000 | +9.2% | 317,200 | -0.8% | 4.58% | +2.0% |
| Q2 2018 | $31,557,000 | -2.0% | 319,791 | -2.8% | 4.49% | -3.2% |
| Q1 2018 | $32,209,000 | +0.0% | 328,962 | -5.2% | 4.64% | +3.1% |
| Q4 2017 | $32,193,000 | +5.4% | 346,831 | -2.6% | 4.50% | -2.8% |
| Q3 2017 | $30,553,000 | +2.3% | 356,183 | +0.6% | 4.63% | +1.2% |
| Q2 2017 | $29,876,000 | +3.3% | 354,026 | +4.7% | 4.58% | +2.2% |
| Q1 2017 | $28,924,000 | +3.3% | 338,175 | -6.0% | 4.48% | -2.9% |
| Q4 2016 | $27,989,000 | +1.3% | 359,576 | +2.0% | 4.61% | -3.1% |
| Q3 2016 | $27,625,000 | +5.5% | 352,402 | +27.7% | 4.76% | -1.8% |
| Q1 2016 | $26,181,000 | +14.6% | 276,001 | +12.2% | 4.84% | +9.0% |
| Q4 2015 | $22,852,000 | +14.0% | 246,041 | +4.6% | 4.44% | -2.9% |
| Q3 2015 | $20,049,000 | -3.7% | 235,295 | -3.3% | 4.57% | +1.2% |
| Q2 2015 | $20,825,000 | – | 243,314 | – | 4.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |